Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas

被引:17
|
作者
Mawrin, Christian
Kirches, Elmar
Diete, Sabine
Wiedemann, Falk R.
Schneider, Thomas
Firsching, Raimund
Kropf, Siegfried
Bogerts, Bernhard
Vorwerk, Christian K.
Kruger, Sabine
Dietzmann, Knut
机构
[1] Otto Von Guericke Univ, Dept Neuropathol, Inst Neuropathol, D-39120 Magdeburg, Germany
[2] Otto Von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany
[3] Otto Von Guericke Univ, Dept Neurosurg, D-39120 Magdeburg, Germany
[4] Otto Von Guericke Univ, Dept Biometr, D-39120 Magdeburg, Germany
[5] Otto Von Guericke Univ, Dept Psychiat, D-39120 Magdeburg, Germany
[6] Otto Von Guericke Univ, Dept Ophthalmol, D-39120 Magdeburg, Germany
[7] Otto Von Guericke Univ, Dept Pathol, D-39120 Magdeburg, Germany
关键词
glioblastoma multiforme; FGFR4; survival;
D O I
10.1016/j.canlet.2005.08.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The FGFR4 codon 388 polymorphism (Arg(388), Arg/Gly(388) or Gly(388)) was determined in glioblastoma multiforme (GBM), anaplastic astrocytomas (AA), diffuse astrocytomas (DA), and control muscles. Arg(388) was rare in AA, GBM, muscles, and was absent in DA. The Arg/Gly(388) and the Gly(388) frequency was equal among GBM and controls. FGFR4 expression was not related to codon 388 in GBM, and no survival differences between Arg/Gly(388) and Gly(388) tumors were found. U87 cells (Arg/Gly(388)) did not show higher invasion than U138 cells (Gly(388)). This suggests that the FGFR4 codon 388 status does not play a major role in malignant gliomas. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 50 条
  • [21] Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis
    A Matakidou
    R el Galta
    M F Rudd
    E L Webb
    H Bridle
    T Eisen
    R S Houlston
    British Journal of Cancer, 2007, 96 : 1904 - 1907
  • [22] Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility
    Chou, Chia-Hsuan
    Hsieh, Ming-Ju
    Chuang, Chun-Yi
    Lin, Jen-Tsun
    Yeh, Chia-Ming
    Tseng, Pao-Yu
    Yang, Shun-Fa
    Chen, Mu-Kuan
    Lin, Chiao-Wen
    ONCOTARGET, 2017, 8 (56) : 96225 - 96238
  • [23] FGFR4 c.1162G > A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma
    Akdeniz Odemis, Demet
    Tuncer, Seref Bugra
    Adamnejad Ghafour, Arash
    Jabbarli, Khariga
    Gider, Yasemin
    Celik, Betul
    Kuru Turkcan, Gozde
    Sukruoglu Erdogan, Ozge
    Kilic Erciyas, Seda
    Avsar, Mukaddes
    Kebudi, Rejin
    Buyukkapu Bay, Sema
    Tuncer, Samuray
    Yazici, Hulya
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [24] FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis
    Kim, Jung Han
    Jeong, Soo Young
    Jang, Hyun Joo
    Park, Sung Taek
    Kim, Hyeong Su
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] FGFR4 IS EXPRESSED IN HUMAN GLIOMAS OF DIFFERENT GRADES AND HISTOLOGIES
    Gjerde, Christiane Helgestad
    Mutlu, Ercan
    Leiss, Lina
    Enger, Per Oyvind
    NEURO-ONCOLOGY, 2014, 16
  • [26] An FGFR4 polymorphism is implicated in the progression of neuroendocrine tumors
    Serra, S.
    Zheng, L.
    Chetty, R.
    Ezzat, S.
    Asa, S. L.
    VIRCHOWS ARCHIV, 2009, 455 : 41 - 41
  • [27] ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma
    Choi, Kyu Young
    Rho, Young Soo
    Kwon, Kee Hwan
    Chung, Eun Jae
    Kim, Jin Hwan
    Park, Il Seok
    Lee, Dong Jin
    CANCER BIOMARKERS, 2012, 12 (03) : 115 - 124
  • [28] Loss of FGFR4 promotes the malignant phenotype of PDAC
    Sabrina D’Agosto
    Francesco Pezzini
    Lisa Veghini
    Pietro Delfino
    Claudia Fiorini
    Gael D. Temgue Tane
    Anais Del Curatolo
    Caterina Vicentini
    Giorgia Ferrari
    Davide Pasini
    Silvia Andreani
    Francesca Lupo
    Elena Fiorini
    Giulia Lorenzon
    Rita T. Lawlor
    Borislav Rusev
    Antonia Malinova
    Claudio Luchini
    Michele Milella
    Elisabetta Sereni
    Antonio Pea
    Claudio Bassi
    Peter Bailey
    Aldo Scarpa
    Emilio Bria
    Vincenzo Corbo
    Oncogene, 2022, 41 : 4371 - 4384
  • [29] Analyis of FGFR4 GIy388Arg polymorphism as a prognostic factor in resected hepatic metastases of colorectal cancer
    Baixeras, Nuria
    Padulles, Laura
    Mollevi, David G.
    Serrano, Teresa
    Condom, Enric
    Ramos, Emilio
    Torras, Jaume
    Salazard, Ramon
    Capella, Gabriel
    Villanueva, Alberto
    VIRCHOWS ARCHIV, 2008, 452 : S214 - S214
  • [30] Loss of FGFR4 promotes the malignant phenotype of PDAC
    D'Agosto, Sabrina
    Pezzini, Francesco
    Veghini, Lisa
    Delfino, Pietro
    Fiorini, Claudia
    Tane, Gael D. Temgue
    Del Curatolo, Anais
    Vicentini, Caterina
    Ferrari, Giorgia
    Pasini, Davide
    Andreani, Silvia
    Lupo, Francesca
    Fiorini, Elena
    Lorenzon, Giulia
    Lawlor, Rita T.
    Rusev, Borislav
    Malinova, Antonia
    Luchini, Claudio
    Milella, Michele
    Sereni, Elisabetta
    Pea, Antonio
    Bassi, Claudio
    Bailey, Peter
    Scarpa, Aldo
    Bria, Emilio
    Corbo, Vincenzo
    ONCOGENE, 2022, 41 (38) : 4371 - 4384